Elevated prodynorphin expression associated with ethanol withdrawal convulsions

A. S. Beadles-Bohling, John Jr Crabbe, Kristine Wiren

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The hypothesis that κ-opioid system activity may in part mediate convulsions exhibited during ethanol withdrawal was tested by exposing Withdrawal Seizure-Prone (WSP) and Withdrawal Seizure-Resistant (WSR) mice to chronic ethanol. Whole brain was harvested for RNA isolation and prodynorphin mRNA steady-state levels in whole brain were examined using Northern blot analysis. The data revealed significantly increased levels of prodynorphin mRNA expression in mice susceptible to ethanol withdrawal convulsions after withdrawal, with no corresponding increase in prodynorphin steady-state levels in mice resistant to ethanol withdrawal convulsions. These findings were not due to basal differences in prodynorphin expression between the WSP and WSR mice. To verify that the differences observed were not due to an ethanol-induced global alteration in gene transcription, mRNA levels of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase were measured. Glyceraldehyde-3-phosphate dehydrogenase expression was unchanged following both chronic exposure to ethanol and chronic exposure followed by withdrawal. These results extend our understanding of prodynorphin's role in generalized seizure activity to include ethanol withdrawal-induced convulsions. Our findings suggest that prodynorphin expression is modulated during ethanol withdrawal convulsions, or alternatively, prodynorphin may mediate the severity of ethanol withdrawal convulsions. Copyright (C) 2000 Elsevier Science Ltd.

Original languageEnglish (US)
Pages (from-to)463-472
Number of pages10
JournalNeurochemistry International
Volume37
Issue number5-6
DOIs
StatePublished - Nov 1 2000

Fingerprint

Seizures
Ethanol
Glyceraldehyde-3-Phosphate Dehydrogenases
Messenger RNA
preproenkephalin
Essential Genes
Brain
Northern Blotting
Opioid Analgesics
RNA
Genes

Keywords

  • κ-Opioid receptors
  • Aversion
  • Convulsions
  • Ethanol
  • Genetics
  • Prodynorphin
  • Selected lines
  • Withdrawal

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Elevated prodynorphin expression associated with ethanol withdrawal convulsions. / Beadles-Bohling, A. S.; Crabbe, John Jr; Wiren, Kristine.

In: Neurochemistry International, Vol. 37, No. 5-6, 01.11.2000, p. 463-472.

Research output: Contribution to journalArticle

@article{12beb5f5255f44998e404a194569bc12,
title = "Elevated prodynorphin expression associated with ethanol withdrawal convulsions",
abstract = "The hypothesis that κ-opioid system activity may in part mediate convulsions exhibited during ethanol withdrawal was tested by exposing Withdrawal Seizure-Prone (WSP) and Withdrawal Seizure-Resistant (WSR) mice to chronic ethanol. Whole brain was harvested for RNA isolation and prodynorphin mRNA steady-state levels in whole brain were examined using Northern blot analysis. The data revealed significantly increased levels of prodynorphin mRNA expression in mice susceptible to ethanol withdrawal convulsions after withdrawal, with no corresponding increase in prodynorphin steady-state levels in mice resistant to ethanol withdrawal convulsions. These findings were not due to basal differences in prodynorphin expression between the WSP and WSR mice. To verify that the differences observed were not due to an ethanol-induced global alteration in gene transcription, mRNA levels of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase were measured. Glyceraldehyde-3-phosphate dehydrogenase expression was unchanged following both chronic exposure to ethanol and chronic exposure followed by withdrawal. These results extend our understanding of prodynorphin's role in generalized seizure activity to include ethanol withdrawal-induced convulsions. Our findings suggest that prodynorphin expression is modulated during ethanol withdrawal convulsions, or alternatively, prodynorphin may mediate the severity of ethanol withdrawal convulsions. Copyright (C) 2000 Elsevier Science Ltd.",
keywords = "κ-Opioid receptors, Aversion, Convulsions, Ethanol, Genetics, Prodynorphin, Selected lines, Withdrawal",
author = "Beadles-Bohling, {A. S.} and Crabbe, {John Jr} and Kristine Wiren",
year = "2000",
month = "11",
day = "1",
doi = "10.1016/S0197-0186(00)00056-5",
language = "English (US)",
volume = "37",
pages = "463--472",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "5-6",

}

TY - JOUR

T1 - Elevated prodynorphin expression associated with ethanol withdrawal convulsions

AU - Beadles-Bohling, A. S.

AU - Crabbe, John Jr

AU - Wiren, Kristine

PY - 2000/11/1

Y1 - 2000/11/1

N2 - The hypothesis that κ-opioid system activity may in part mediate convulsions exhibited during ethanol withdrawal was tested by exposing Withdrawal Seizure-Prone (WSP) and Withdrawal Seizure-Resistant (WSR) mice to chronic ethanol. Whole brain was harvested for RNA isolation and prodynorphin mRNA steady-state levels in whole brain were examined using Northern blot analysis. The data revealed significantly increased levels of prodynorphin mRNA expression in mice susceptible to ethanol withdrawal convulsions after withdrawal, with no corresponding increase in prodynorphin steady-state levels in mice resistant to ethanol withdrawal convulsions. These findings were not due to basal differences in prodynorphin expression between the WSP and WSR mice. To verify that the differences observed were not due to an ethanol-induced global alteration in gene transcription, mRNA levels of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase were measured. Glyceraldehyde-3-phosphate dehydrogenase expression was unchanged following both chronic exposure to ethanol and chronic exposure followed by withdrawal. These results extend our understanding of prodynorphin's role in generalized seizure activity to include ethanol withdrawal-induced convulsions. Our findings suggest that prodynorphin expression is modulated during ethanol withdrawal convulsions, or alternatively, prodynorphin may mediate the severity of ethanol withdrawal convulsions. Copyright (C) 2000 Elsevier Science Ltd.

AB - The hypothesis that κ-opioid system activity may in part mediate convulsions exhibited during ethanol withdrawal was tested by exposing Withdrawal Seizure-Prone (WSP) and Withdrawal Seizure-Resistant (WSR) mice to chronic ethanol. Whole brain was harvested for RNA isolation and prodynorphin mRNA steady-state levels in whole brain were examined using Northern blot analysis. The data revealed significantly increased levels of prodynorphin mRNA expression in mice susceptible to ethanol withdrawal convulsions after withdrawal, with no corresponding increase in prodynorphin steady-state levels in mice resistant to ethanol withdrawal convulsions. These findings were not due to basal differences in prodynorphin expression between the WSP and WSR mice. To verify that the differences observed were not due to an ethanol-induced global alteration in gene transcription, mRNA levels of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase were measured. Glyceraldehyde-3-phosphate dehydrogenase expression was unchanged following both chronic exposure to ethanol and chronic exposure followed by withdrawal. These results extend our understanding of prodynorphin's role in generalized seizure activity to include ethanol withdrawal-induced convulsions. Our findings suggest that prodynorphin expression is modulated during ethanol withdrawal convulsions, or alternatively, prodynorphin may mediate the severity of ethanol withdrawal convulsions. Copyright (C) 2000 Elsevier Science Ltd.

KW - κ-Opioid receptors

KW - Aversion

KW - Convulsions

KW - Ethanol

KW - Genetics

KW - Prodynorphin

KW - Selected lines

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=0034335361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034335361&partnerID=8YFLogxK

U2 - 10.1016/S0197-0186(00)00056-5

DO - 10.1016/S0197-0186(00)00056-5

M3 - Article

VL - 37

SP - 463

EP - 472

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 5-6

ER -